Q4 2019 Vascular Biogenics Ltd Earnings Call Transcript
Greetings and welcome to the VBL Therapeutics Fourth Quarter and Full Year 2019 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Mr. Michael Wood with LifeSci Advisors. Thank you. You may begin.
Thank you, operator. Good morning and thank you all for participating in today's year-end 2019 results and corporate update call for VBL Therapeutics. Leading the call this morning will be Professor Dror Harats, CEO of the company; and Amos Ron, the company's CFO. Our press release with the financial results became available at 10:00 Eastern time today and can be found on the Investors page of the company's website.
Before we begin, I'd like to remind everyone that various remarks about future expectations, plans, prospects constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995.
VBL cautions that these forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |